logo

For the Inventor, By the Inventor

Harleysville, PA, United States of America

Henry M Sarau

This inventor holds 13 USPTO granted patents and 1 published patent application. Top assignees: Smithkline Beecham Corporation, Smithkline Beckman Corporation, Sb Laboratoires Pharmaceutiques. Active years: 1987-2003.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Henry M Sarau. Retrieved from https://idiyas.com/inventor/henry-m-sarau

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 13 

% Patents Active = 92.3

Average Co-Inventor Count = 5.7

ph-index = 4

Forward Citations = 113(Granted Patents)


Location History:

  • Hatfield, PA (US) (1987 - 1992)
  • Harleyville, PA (US) (2001 - 2002)
  • Harleysville, PA (US) (1989 - 2003)

Company Filing History:

goldMedal13 out of 2,198 
 
Smithkline Beecham Corporation
 patents
silverMedal2 out of 207 
 
Smithkline Beckman Corporation
 patents
bronzeMedal1 out of 1 
 
Sb Laboratoires Pharmaceutiques
 patent
where one patent can have more than one assignee

Years Active: 1987-2003

Loading Chart...
13 patents (USPTO):Explore Patents
1. 6506878 - HMTF81 human 7-transmembrane receptor (2003-01-14),
2. 6344342 - Human G protein coupled lysophosphatidic acid receptor (2002-02-05),
3. 6287801 - Nucleic acids encoding the G-protein coupled receptor HNFDS78 (2001-09-11),
4. 6242572 - Human G protein coupled lysophosphatidic acid receptor (2001-06-05),
5. 6238873 - Methods of screening for agonists and antagonists of the interaction between the human KIAA0001 receptor and ligands thereof (2001-05-29),
6. 6200775 - cDNA clone HMTMF81 that encodes a novel human 7-transmembrane receptor (2001-03-13),
7. 6159700 - Method of finding agonist and antagonist to human and rat GPR14 (2000-12-12),
8. 6153441 - Methods of screening for agonists and antagonists for human CCR7 (2000-11-28),
9. 6133420 - GPR14 polypeptides (2000-10-17),
10. 5942405 - Therapeutic and screening methods using C3a receptor and C3a (1999-08-24),
11. 5134150 - Inhibition of the 5-lipoxygenase pathway (1992-07-28),
12. 4871771 - Leukotriene antagonists (1989-10-03),
13. 4686231 - Inhibition of 5-lipoxygenase products (1987-08-11),

Certainly! Here is the article about inventor Henry M Sarau:

Title: Henry M Sarau: Pioneering Innovations in Biomedical Sciences

Introduction:

Henry M Sarau, a distinguished inventor hailing from Harleyville, Pennsylvania (US), has made significant contributions to the field of biomedical sciences. With a total of 13 patents to his name, his groundbreaking work has paved the way for advancements in the treatment of various infections and diseases.

Latest Patents:

Henry M Sarau's latest patents include the HMTF81 human 7-transmembrane receptor and the HOFNH30 human G protein coupled lysophosphatidic acid receptor. These patents disclose methods for producing polypeptides and polynucleotides using recombinant techniques and offer innovative protocols for the treatment of infections, cancers, and neurological disorders. Diagnostic assays for various conditions are also a key highlight of his recent inventions.

Career Highlights:

Henry M Sarau has showcased his exceptional skills and expertise while working with renowned companies such as SmithKline Beecham Corporation and SmithKline Beckman Corporation. His innovative research and patent applications have garnered recognition within the industry, establishing him as a trailblazer in the field of biomedical innovation.

Collaborations:

Throughout his illustrious career, Henry M Sarau has collaborated with esteemed professionals in the field, including Robert S Ames and James J Foley. Together, they have fostered a culture of innovation and excellence, driving forward cutting-edge research and development initiatives.

Conclusion:

In conclusion, Henry M Sarau's dedication to innovation and his passion for advancing biomedical sciences have solidified his reputation as a leading inventor in the industry. His patents reflect a deep commitment to improving healthcare outcomes and addressing critical medical challenges, making him a pioneer in the realm of biomedical innovation.

If you have any further requests or need more information, feel free to ask!

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…